Fernandez-Ananin Sonia, Fernández Arnulfo F, Balagué Carmen, Sacoto David, Targarona Eduardo Maria
Department of General and Digestive Surgery, Hospital De La Santa Creu I Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Department of General and Digestive Surgery, Centro Laparoscópico Dr. Ballesta, Hospital Quirón Teknon, Barcelona, Spain.
J Minim Access Surg. 2018 Jul-Sep;14(3):177-184. doi: 10.4103/jmas.JMAS_94_17.
Surgical treatment of achalasia fails in 10%-20% of patients. The most frequent responsible cause is the performance of an incomplete myotomy at primary surgery. The treatment when the failure happens is not well defined. In this study, we review and evaluate the possible treatments to be carried out when surgical myotomy fails. We define its benefits and results, with the purpose of defining a therapeutic algorithm.
The systematic review was performed following the guidelines established by the Meta-analysis of Observational Studies in Epidemiology statement. We searched several electronic databases (MEDLINE, PubMED, EMBASE and Cochrane) from January 1991 to March 2017, with the keywords 'recurrent achalasia' 'POEM remyotomy', 'esophagomyotomy failure', 'Heller myotomy failure', 'myotomy failure', 'pneumatic balloon dilatation achalasia' and combinations between them, 'redo Heller', 'redo myotomy', 'reoperative Heller'.
A total of 61 observational studies related to the treatment of patients with failure of Heller's myotomy were initially found. Finally, 37 articles were included in our study that provided data on 289 patients. Of these 289 patients, diagnosed of failed Heller's myotomy, 87 were treated with pneumatic dilatation (PD), 166 underwent surgical revision and finally 36 were treated with POEM. No randomised controlled trial was identified.
The three therapeutic options analysed in this review are effective and safe in the treatment of patients with achalasia with failure of surgical myotomy. The best results can be achieved following an algorithm similar to the one proposed here, where each procedure must be performed by well-experienced team in the selected modality.
贲门失弛缓症的手术治疗在10%-20%的患者中失败。最常见的原因是初次手术时肌层切开不完全。失败发生时的治疗方法尚不明确。在本研究中,我们回顾并评估手术肌层切开失败时可能的治疗方法。我们定义其益处和结果,旨在确定一种治疗算法。
按照《流行病学观察性研究的元分析声明》制定的指南进行系统评价。我们检索了1991年1月至2017年3月的几个电子数据库(MEDLINE、PubMED、EMBASE和Cochrane),关键词为“复发性贲门失弛缓症”“POEM再肌层切开术”“食管肌层切开术失败”“赫勒肌层切开术失败”“肌层切开术失败”“气囊扩张治疗贲门失弛缓症”及其组合、“再次赫勒手术”“再次肌层切开术”“再次手术赫勒肌层切开术”。
最初共找到61项与赫勒肌层切开术失败患者治疗相关的观察性研究。最终,我们的研究纳入了37篇文章,这些文章提供了289例患者的数据。在这289例被诊断为赫勒肌层切开术失败的患者中,87例接受了气囊扩张治疗(PD),166例接受了手术翻修,最后36例接受了POEM治疗。未发现随机对照试验。
本综述分析的三种治疗选择在治疗手术肌层切开失败的贲门失弛缓症患者中是有效且安全的。遵循类似于此处提出的算法可取得最佳结果,其中每个程序必须由所选方式经验丰富的团队进行。